Literature DB >> 15028829

Adjuvant therapy for pancreatic cancer--the debate continues.

Michael A Choti.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15028829     DOI： 10.1056/NEJMe048002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

Review 1.  Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma.

Authors:  Daneng Li; Eileen M O'Reilly
Journal:  Semin Oncol       Date:  2014-12-09       Impact factor: 4.929

2.  On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer.

Authors:  Michael C Garofalo; William F Regine; Ming T Tan
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  The role of radiotherapy in management of pancreatic cancer.

Authors:  Fen Wang; Parvesh Kumar
Journal:  J Gastrointest Oncol       Date:  2011-09

4.  Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy.

Authors:  Yaojun Zhang; Adam E Frampton; Charis Kyriakides; Jan J Bong; Nagy Habib; Raida Ahmad; Long R Jiao
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-04       Impact factor: 4.553

5.  Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion.

Authors:  Takehiro Okabayashi; Yasuo Shima; Jun Iwata; Sojiro Morita; Tatsuaki Sumiyoshi; Akihito Kozuki; Yuichi Saisaka; Teppei Tokumaru; Tatsuo Iiyama; Yoshihiro Noda; Yasuhiro Hata; Manabu Matsumoto
Journal:  Langenbecks Arch Surg       Date:  2015-05-06       Impact factor: 3.445

6.  Pancreatic cancer: translational research aspects and clinical implications.

Authors:  Daniel Ansari; Bi-Cheng Chen; Lei Dong; Meng-Tao Zhou; Roland Andersson
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 7.  Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?

Authors:  Michael D Chuong; Drexell H Boggs; Kruti N Patel; William F Regine
Journal:  J Gastrointest Oncol       Date:  2014-06

8.  Stage-specific survival differences associated with postoperative radiotherapy for gastrointestinal cancers.

Authors:  John S Moody; Stephen M Sawrie; Kevin R Kozak; John P Plastaras; George Howard; James A Bonner
Journal:  J Gastrointest Cancer       Date:  2009-03-18

9.  Optimal adjuvant therapy for resected pancreatic cancer: chemotherapy or chemoradiotherapy?

Authors:  Michael C Garofalo; Elizabeth M Nichols; William F Regine
Journal:  Gastrointest Cancer Res       Date:  2007-09

10.  Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Authors:  Charles C Hsu; Joseph M Herman; Michele M Corsini; Jordan M Winter; Matthew D Callister; Michael G Haddock; John L Cameron; Timothy M Pawlik; Richard D Schulick; Christopher L Wolfgang; Daniel A Laheru; Michael B Farnell; Michael J Swartz; Leonard L Gunderson; Robert C Miller
Journal:  Ann Surg Oncol       Date:  2010-01-20       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.